IFM Investors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $142M | Buy |
559,954
+54,420
| +11% | +$12.7M | 0.94% | 15 |
|
|
2026
Q1 | $124M | Buy |
505,534
+15,989
| +3% | +$3.72M | 1.03% | 14 |
|
|
2025
Q4 | $101M | Buy |
489,545
+17,014
| +4% | +$3.36M | 0.85% | 15 |
|
|
2025
Q3 | $84.9M | Sell |
472,531
-1,846
| -0.4% | -$316K | 0.75% | 20 |
|
|
2025
Q2 | $72.5M | Buy |
474,377
+17,131
| +4% | +$2.63M | 0.69% | 20 |
|
|
2025
Q1 | $75.8M | Buy |
457,246
+3,347
| +0.7% | +$524K | 0.82% | 19 |
|
|
2024
Q4 | $65.6M | Sell |
453,899
-32,749
| -7% | -$5.07M | 0.67% | 22 |
|
|
2024
Q3 | $78.9M | Sell |
486,648
-1,720
| -0.4% | -$274K | 0.76% | 19 |
|
|
2024
Q2 | $71.4M | Sell |
488,368
-100
| -0% | -$14.9K | 0.72% | 19 |
|
|
2024
Q1 | $77.3M | Sell |
488,468
-1,309
| -0.3% | -$208K | 0.84% | 18 |
|
|
2023
Q4 | $76.8M | Sell |
489,777
-13,680
| -3% | -$2.1M | 0.93% | 16 |
|
|
2023
Q3 | $78.4M | Sell |
503,457
-12,040
| -2% | -$1.99M | 1.03% | 14 |
|
|
2023
Q2 | $85.3M | Buy |
515,497
+22,986
| +5% | +$3.71M | 1.12% | 10 |
|
|
2023
Q1 | $76.3M | Buy |
492,511
+12,493
| +3% | +$2.02M | 1.16% | 11 |
|
|
2022
Q4 | $84.8M | Buy |
480,018
+17,909
| +4% | +$3.09M | 1.42% | 7 |
|
|
2022
Q3 | $75.5M | Buy |
462,109
+15,053
| +3% | +$2.55M | 1.37% | 8 |
|
|
2022
Q2 | $79.4M | Buy |
447,056
+28,057
| +7% | +$5M | 1.39% | 8 |
|
|
2022
Q1 | $74.3M | Buy |
418,999
+70,221
| +20% | +$11.9M | 1.15% | 10 |
|
|
2021
Q4 | $59.7M | Sell |
348,778
-4,001
| -1% | -$655K | 1.09% | 11 |
|
|
2021
Q3 | $57M | Buy |
352,779
+3,757
| +1% | +$641K | 1.18% | 10 |
|
|
2021
Q2 | $57.5M | Buy |
349,022
+61,448
| +21% | +$10.2M | 1.18% | 9 |
|
|
2021
Q1 | $47.3M | Buy |
287,574
+33,306
| +13% | +$5.39M | 1.26% | 9 |
|
|
2020
Q4 | $40M | Buy |
254,268
+36,217
| +17% | +$5.34M | 1.27% | 8 |
|
|
2020
Q3 | $32.5M | Buy |
218,051
+24,128
| +12% | +$3.57M | 1.36% | 7 |
|
|
2020
Q2 | $27.3M | Sell |
193,923
-74,368
| -28% | -$10.8M | 1.4% | 7 |
|
|
2020
Q1 | $35.7M | Sell |
268,291
-9,304
| -3% | -$1.32M | 1.6% | 5 |
|
|
2019
Q4 | $40.5M | Sell |
277,595
-9,149
| -3% | -$1.24M | 1.43% | 8 |
|
|
2019
Q3 | $37.1M | Buy |
286,744
+98,316
| +52% | +$13M | 1.37% | 8 |
|
|
2019
Q2 | $26.2M | Buy |
188,428
+14,568
| +8% | +$2.02M | 1.49% | 5 |
|
|
2019
Q1 | $24.3M | Buy |
173,860
+18,298
| +12% | +$2.45M | 1.56% | 5 |
|
|
2018
Q4 | $20.1M | Buy |
155,562
+13,932
| +10% | +$1.94M | 1.62% | 4 |
|
|
2018
Q3 | $19.6M | Buy |
141,630
+20,106
| +17% | +$2.67M | 1.49% | 7 |
|
|
2018
Q2 | $14.7M | Buy |
121,524
+37,856
| +45% | +$4.72M | 1.39% | 9 |
|
|
2018
Q1 | $10.7M | Buy |
83,668
+8,454
| +11% | +$1.14M | 1.54% | 6 |
|
|
2017
Q4 | $10.5M | Sell |
75,214
-274
| -0.4% | -$38.2K | 1.66% | 6 |
|
|
2017
Q3 | $9.81M | Buy |
75,488
+1,355
| +2% | +$180K | 1.66% | 5 |
|
|
2017
Q2 | $9.81M | Buy |
74,133
+18,644
| +34% | +$2.38M | 1.76% | 4 |
|
|
2017
Q1 | $6.91M | Buy |
55,489
+20,460
| +58% | +$2.44M | 1.75% | 4 |
|
|
2016
Q4 | $4.04M | Buy |
+35,029
| New | +$4.05M | 1.9% | 4 |
|
Other funds holding JNJ
IFM Investors's JNJ Position: Q2 2026 in Review
IFM Investors increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $12.7M and bringing the position to 559,954 shares worth $142M. The position accounts for 0.94% of the portfolio, ranked #15.
IFM Investors first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- IFM Investors held 559,954 shares of Johnson & Johnson worth $142M as of Q2 2026.
- IFM Investors bought 54,420 Johnson & Johnson shares in Q2 2026, an estimated $12.7M.
- Johnson & Johnson made up 0.94% of IFM Investors's portfolio in Q2 2026, its #15 holding.
- IFM Investors first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.